Sana Biotechnology, Inc. Operating Income (Loss) in USD from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sana Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to Q3 2025.
  • Sana Biotechnology, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$43.5M, a 29.5% increase year-over-year.
  • Sana Biotechnology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$240M, a 23.2% increase year-over-year.
  • Sana Biotechnology, Inc. annual Operating Income (Loss) for 2024 was -$273M, a 6.97% increase from 2023.
  • Sana Biotechnology, Inc. annual Operating Income (Loss) for 2023 was -$293M, a 7.55% decline from 2022.
  • Sana Biotechnology, Inc. annual Operating Income (Loss) for 2022 was -$273M, a 23.6% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

Sana Biotechnology, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$240M -$43.5M +$18.2M +29.5% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$258M -$95M -$45.6M -92.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 -$213M -$50.6M +$60.1M +54.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 -$273M -$50.9M +$39.8M +43.9% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-17
Q3 2024 -$312M -$61.8M -$59.6M -2732% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 -$253M -$49.4M +$66.9M +57.5% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 -$320M -$111M -$26.7M -31.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 -$293M -$90.6M -$8.83M -10.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-17
Q3 2023 -$284M -$2.18M +$84M +97.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$368M -$116M -$43.4M -59.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$325M -$84.1M -$52.4M -165% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$273M -$81.8M +$29.5M +26.5% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-17
Q3 2022 -$302M -$86.2M -$2.76M -3.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$299M -$72.9M -$91.5M -493% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$208M -$31.7M +$149M +82.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$357M -$111M +$2.05M +1.81% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$359M -$83.4M -$31.8M -61.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$327M $18.6M +$106M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$434M -$181M -$147M -443% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$286M -$113M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-16
Q3 2020 -$51.6M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$87.9M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$33.3M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05

Sana Biotechnology, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$273M +$20.4M +6.97% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-17
2023 -$293M -$20.6M -7.55% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-17
2022 -$273M +$84.3M +23.6% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-17
2021 -$357M -$70.8M -24.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$286M -$145M -103% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 -$141M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.